Vaginal probiotic study shows promise for women's health without antibiotics

A new clinical trial found that Lactobacillus crispatus probiotics—delivered orally and vaginally—may improve vaginal health outcomes. The finding could reshape how healthcare systems and pharmaceutical companies approach bacterial infections in women, potentially reducing reliance on antibiotics and opening a new market segment for microbiome-targeted therapeutics.

Originaltitel: Impact of <i>Lactobacillus crispatus</i>-containing oral and vaginal probiotics on vaginal health: a randomised double-blind placebo controlled clinical trial